Feedback / Questions
ProTmune (FT1050+FT4145 programmed mPB) - Fate Therap
ProTmune: Protection of composition-of-matter patents until 2032
(Fate Therapeutics)
-
Oct 30, 2018 -
Corporate Presentation
Patent
•
Graft versus Host Disease • Immunology
https://fatetherapeuticsinc.gcs-web.com/static-files/f51a4fe3-7025-4ac8-8145-c19484cd67f5
Oct 30, 2018
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious